OMB Submits Proposed Regulation to Rescind Insulin and EpiPen EO

This week, it was announced on the OMB website that the HRSA Bureau of Primary Health Care (BPHC) has submitted for OMB review a proposed regulation that would rescind the Trump-era rule around FQHCs, insulin and EpiPen’s. While this is a good sign, please know that there are several steps that must be taken before the regulation could actually be rescinded: the Proposed Rule must be published; there will be a public comment period and then BPHC will review the comments and issue a Final Rule.